RxDoctor Payments Data

Samuel Creekmore, MD

Family Medicine · New Albany, MSNPI 1578538591

Payments from drug & device makers

$1,927in general payments, 2019–2025

Across 142 payments — averaging $13.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$594
  • Novo Nordisk$182
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$153
  • Sunovion Pharmaceuticals Inc.$141
  • Boehringer Ingelheim$118
  • AstraZeneca$88
  • plus $650 from 20 others

What the payments were for

  • Food & beverage$1,927100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,927 in reported general payments places this provider in the 65th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$100,799
Medicare patients
285
Services billed
2,633

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$57,861
EliquisApixaban86$34,063
XareltoRivaroxaban44$19,915
JanuviaSitagliptin Phosphate24$18,141
GemtesaVibegron69$18,040
JardianceEmpagliflozin19$17,652
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$15,323
LinzessLinaclotide15$12,775
EntrestoSacubitril/Valsartan18$9,991
Metformin Hcl100$8,160
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$6,628
TradjentaLinagliptin23$5,902
Gabapentin358$5,066
Divalproex Sodium42$3,153
Pantoprazole Sodium333$2,633

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Levemir$182$59,14767 claims
PfizerEliquis$30$34,06386 claims
Boehringer IngelheimJardiance, Tradjenta$118$23,55442 claims
Sumitomo Pharma America, Inc.Gemtesa$21$18,04069 claims
GSKTrelegy Ellipta$58$15,32321 claims
AbbVieLinzess$594$12,77515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 971 family medicine providers in Mississippi.

Other family medicine in New Albany

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →